InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Canada | Supplements


  • Breaking the promise doctrine in Canada?

    25 Aug 2016

    The Supreme Court of Canada will rule on the controversial issue of the “promise of the patent”. Practitioners are hoping for guidance on whether the doctrine is valid for analysing a patent’s utility, say Michael Loney and Natalie Rahhal

  • How the Canadian Patent Appeal Board has dealt with patent-eligibility

    25 Aug 2016

    Software patent-eligibility was clarified in the Federal Court of Appeal’s Amazon.com decision in 2011. Grant Tisdall and Scott Douglas of Gowling WLG analyse how the patent Appeal Board has addressed computer-implemented inventions since then

  • Understanding the impact of Canada’s IP law reform

    25 Aug 2016

    Canada is undergoing extensive domestic IP law reform to implement several international treaties. David E Schwartz and Kendra L Cann of Smart & Biggar analyse the biggest changes

profile

Managing IP

ManagingIP

ManagingIP profile

ICYMI: Our report on this week's #SCOTUS ruling in Star Athletica v Varsity Brands https://t.co/Rf3TWplNUrhttps://t.co/TrZ5YcvKQr

Mar 24 2017 01:35 ·  reply ·  retweet ·  favourite
ManagingIP profile

@Oblon_IP @PatentPostGrant Congratulations Scott! #mipawards

Mar 24 2017 01:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

@KellyIPllp Well done to all at the firm!

Mar 24 2017 02:16 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements